You may recall dear readers my discussion about the sale of Allergan to Pfizer.  Well, the deal fell through.   The Treasury Department put into play new corporate tax rules that take the advantage out of moving a U.S. based corporation to a foreign country which has lower corporate tax rates.  The important thing to note is this….. Despite the cancellation of the sale of Allergan to Pfizer, the price increases put into effect this year (2016) by Allergan have not been rescinded.


Ah, the price of beauty!!